News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
217–252
Matches
838
Sources here
21
Companies here
12
Search results Stored financial headlines

Active search

838 matching headlines

Ticker or company: IVAMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress

Innoviva, Inc. (NASDAQ: INVA) announced strong second-quarter 2026 financial results, driven by robust performance from its royalty portfolio and significant growth in Innoviva Specialty Therapeutics (IST) net product sales. The company achieved 19% year-on-year total revenue growth to $119.6 million and saw IST U.S. …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Inventiva targets MASH with lanifibranor, eyeing key Phase 3 results in Q4 2026 amid strong liquidity.

Inventiva is developing lanifibranor, an oral pan-PPAR agonist for MASH treatment, which offers dual metabolic and anti-fibrotic benefits and complements existing therapies. The company is well-funded through mid-2027 and has improved governance. Key Phase 3 trial results are anticipated in Q4 2026, which could …

IVA main company
Sharemaestro market context Price below Trend Line 52 weeks +2.8% IVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Andrew Miles Snyder Sells 2,489,618 Shares of Clarivate (NYSE:CLVT) Stock

Clarivate director Andrew Miles Snyder sold 2,489,618 shares of CLVT stock at an average price of $1.94, totaling approximately $4.83 million, reducing his direct ownership by 39.23%. This transaction occurred as Clarivate shares traded near their 52-week low and the company reported quarterly EPS …

CLVT main company
Sharemaestro market context Price below Trend Line 52 weeks -57.1% · Next-week setup negative 41.5% CLVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q2 2026 Trivago NV Earnings Call Transcript

Trivago NV (TRVG) reported strong Q2 2026 results, marking its sixth consecutive quarter of double-digit revenue growth with a 21% year-over-year increase, exceeding expectations. The company achieved a positive adjusted EBITDA of EUR1.1 million, its first positive Q2 since 2023, and raised its full-year …

TRVG main company
Sharemaestro market context Trend signal active 52 weeks +57.4% · Next-week setup negative 42.7% TRVG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

trivago Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, trivago NV (TRVG) has approximately 516 total employees worldwide, marking a 13.8% growth since 2023. The company is actively hiring, with 40 job postings in 2026, and its workforce is primarily concentrated in Western Europe. The average salary is $64,520, …

TRVG main company
Sharemaestro market context Trend signal active 52 weeks +57.4% · Next-week setup negative 42.7% TRVG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

trivago Q2 2026 slides: revenue surges 21%, first positive EBITDA

Trivago reported a strong second quarter in 2026, with revenue surging 21% year-over-year to €168.4 million and achieving its first positive adjusted EBITDA of €1.1 million since 2023. Despite these positive results and beating Wall Street expectations, shares declined slightly, reflecting investor concerns about …

TRVG main company
Sharemaestro market context Trend signal active 52 weeks +57.4% · Next-week setup negative 42.7% TRVG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Innoviva (INVA) Q2 Earnings and Revenues Top Estimates

Innoviva (INVA) reported Q2 earnings of $0.59 per share, exceeding the Zacks Consensus Estimate of $0.56, and revenues of $119.59 million, also surpassing estimates by 5.63%. Despite outperforming estimates four times over the past year, the stock currently holds a Zacks Rank #5 (Strong …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova PLC 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LIVN) 2026-08-05

LivaNova PLC (NASDAQ: LIVN) has released its Q2 2026 earnings call presentation. The company reported an EPS of $1.26, beating estimates by $0.17, and revenue of $390.60 million, a 10.81% year-over-year increase, beating estimates by $10.02 million. This presentation provides details on their financial …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $119.6M, vs. FactSet Est of $111.0M

Innoviva, Inc. reported its Q2 revenue of $119.6 million, surpassing the FactSet estimate of $111.0 million. The company, a diversified holding company with a focus on healthcare assets and royalties from respiratory products, also announced an update on its equity buyback plan. Innoviva's product …

INVA main company
Sharemaestro market context Price below Trend Line 52 weeks +5.1% · Next-week setup negative 42.4% INVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Capital Fund Management discloses net short position in Abivax shares

Capital Fund Management has revealed a 0.5% net short position in Abivax shares. This news brief was generated by Public Technologies using AI and is based on original content published by Abivax SA on August 5, 2026. The information provided is for informational purposes …

ABVX main company
Sharemaestro market context Trend signal active 52 weeks +53.9% · Next-week setup positive 57.2% ABVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vivani Medical (VANI) to Announce Earnings on Wednesday

Vivani Medical (VANI) is set to release its Q2 2026 earnings before market open on Wednesday, August 12th, with analysts expecting a loss of $0.08 per share. The company previously matched consensus estimates with a similar loss in Q1. Insider transactions show Director Gregg …

VANI main company
Sharemaestro market context Trend signal active 52 weeks +12.9% · Next-week setup negative 42.2% VANI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova (LIVN) Reports Q2 Earnings: What Key Metrics Have to Say

LivaNova (LIVN) reported strong Q2 2026 earnings, with revenue of $390.6 million and EPS of $1.26, surpassing Wall Street expectations. The company exceeded consensus estimates for net sales in Neuromodulation, Cardiopulmonary, and Other segments. Despite the positive results, LivaNova's stock performance over the past …

LIVN main company L2IV34 main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova PLC (LIVN) Hits Fresh High: Is There Still Room to Run?

A strong stock as of late has been LivaNova (LIVN). Shares have been marching higher, with the stock up 2.1% over the past month. The stock hit a new 52-week high of $85.76 in the previous session. LivaNova has gained 38.7% since the start …

LIVN main company L2IV34 main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova exceeds second-quarter forecasts and increases 2026 outlook

Graph showing growth ©Adobe Stock Images LivaNova (NASDAQ:LIVN) reported second-quarter results that surpassed Wall Street expectations, prompting the medical technology company to raise its earnings and revenue guidance for the full year. The stronger performance helped lift the shares around 1.3% in after-hours trading. …

LIVN main company L2IV34 main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (LIVN) LivaNova PLC Reports Q2 Revenue $390.6M, vs. FactSet Est of $380.5M

LivaNova PLC (LIVN) announced Q2 revenue of $390.6 million, surpassing the FactSet estimate of $380.5 million. The company also reported Q2 adjusted EPS of $1.26 per share, exceeding the FactSet estimate of $1.09, and raised its fiscal 2026 adjusted EPS outlook to a range …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova plc (LIVN) Tops Q2 EPS by 17c ; Offers Guidance

LivaNova plc (LIVN) exceeded analyst expectations for its Q2 earnings, reporting an EPS of $1.26 against an estimated $1.09, and revenue of $390.6 million compared to the $380.57 million consensus. The company also provided optimistic guidance for FY2026 EPS, projecting $4.30-$4.40, which is above …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

– Delivered double-digit reported revenue growth of 10.8%, with constant-currency revenue growth of 9.8% – Raised full-year 2026 revenue and adjusted diluted earnings per share guidance(1) – Entered into a long-term agreement with Thermo Fisher Scientific to strengthen oxygenator component supply to expand manufacturing …

L2IV34 main company
Sharemaestro market context Stored weekly price path 5 weeks +3.9% · Next-week setup positive 66.2% L2IV34 stored weekly price path from 17 Jul 2026 to 14 Aug 2026

LivaNova PLC: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

LivaNova PLC reported strong second-quarter 2026 results, with reported revenue growth of 10.8% and constant-currency growth of 9.8%. The company raised its full-year 2026 revenue and adjusted diluted earnings per share guidance, citing sustained performance in its Cardiopulmonary and Neuromodulation businesses. LivaNova also announced …

LIVN main company
Sharemaestro market context Trend signal active 52 weeks +47.1% · Next-week setup negative 40.6% LIVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

[6-K] trivago N.V. Current Report (Foreign Issuer)

Trivago N.V. (TRVG) filed a 6-K report detailing its unaudited second-quarter and six-month financial results through June 30, 2026. Key highlights include holding 1,659,090 repurchased Class A shares in treasury, an increase in authorized Class A shares for its incentive plan, and financial data …

TRVG main company
Sharemaestro market context Trend signal active 52 weeks +57.4% · Next-week setup negative 42.7% TRVG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arrowstreet Capital Limited Partnership Acquires Shares of 1,320,982 Clarivate PLC $CLVT

Arrowstreet Capital Limited Partnership recently acquired 1,320,982 shares of Clarivate PLC (NYSE:CLVT) worth approximately $3.34 million, marking a new position and a 0.21% stake in the company. Despite Clarivate beating analyst EPS estimates with $0.19, its revenue of $587.3 million fell short of expectations …

CLVT main company
Sharemaestro market context Price below Trend Line 52 weeks -57.1% · Next-week setup negative 41.5% CLVT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context